| Current understanding on EGFR and Wnt/β-catenin signaling in glioma and their possible crosstalk I Paul, S Bhattacharya, A Chatterjee, MK Ghosh Genes & cancer 4 (11-12), 427-446, 2013 | 186 | 2013 |
| Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases S Bhattacharya, D Chakraborty, M Basu, MK Ghosh Signal transduction and targeted therapy 3 (1), 17, 2018 | 134 | 2018 |
| Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cells KKN Guturi, T Mandal, A Chatterjee, M Sarkar, S Bhattacharya, ... Journal of Biological Chemistry 287 (22), 18287-18296, 2012 | 82 | 2012 |
| HAUSP, a novel deubiquitinase for Rb–MDM 2 the critical regulator S Bhattacharya, MK Ghosh The FEBS journal 281 (13), 3061-3078, 2014 | 67 | 2014 |
| BETP degradation simultaneously targets acute myelogenous leukemic stem cells and the microenvironment S Piya, H Mu, S Bhattacharya, PL Lorenzi, RE Davis, T McQueen, ... The Journal of clinical investigation 129 (5), 1878-1894, 2019 | 63 | 2019 |
| 2, 2′-diphenyl-3, 3′-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway A Bhowmik, N Das, U Pal, M Mandal, S Bhattacharya, M Sarkar, ... PLoS One 8 (3), e59798, 2013 | 46 | 2013 |
| Cell death and deubiquitinases: perspectives in cancer S Bhattacharya, MK Ghosh BioMed research international 2014, 2014 | 43 | 2014 |
| HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP S Bhattacharya, MK Ghosh Cellular Oncology 38, 265-277, 2015 | 34 | 2015 |
| Bromodomain inhibitors: what does the future hold S Bhattacharya, S Piya, G Borthakur Clin. Adv. Hematol. Oncol 16, 504-515, 2018 | 21 | 2018 |
| Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL S Piya, Y Yang, S Bhattacharya, P Sharma, H Ma, H Mu, H He, V Ruvolo, ... Leukemia 36 (5), 1261-1273, 2022 | 14 | 2022 |
| Simultaneous inhibition of key growth pathways in melanoma cells and tumor regression by a designed bidentate constrained helical peptide A Dhar, S Mallick, P Ghosh, A Maiti, I Ahmed, S Bhattacharya, T Mandal, ... Peptide Science 102 (4), 344-358, 2014 | 12 | 2014 |
| Effects of degradations on deep neural network architectures. arXiv 2018 P Roy, S Ghosh, S Bhattacharya, U Pal arXiv preprint arXiv:1807.10108, 1807 | 12 | 1807 |
| Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy W Zhang, G Yu, H Zhang, M Basyal, C Ly, B Yuan, V Ruvolo, S Piya, ... Haematologica 108 (6), 1500, 2023 | 11 | 2023 |
| BRD4 proteolysis targeting chimera (PROTAC) ARV-825, causes sustained degradation of BRD4 and modulation of chemokine receptors, cell adhesion and metabolic targets in leukemia … S Piya, S Bhattacharya, H Mu, PL Lorenzi, T McQueen, ER Davis, ... Blood 128 (22), 748, 2016 | 9 | 2016 |
| Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) overcomes adaptive drug resistance in acute myelogenous leukemia S Bhattacharya, S Piya, H Ma, P Sharma, Q Zhang, N Baran, VR Ruvolo, ... Molecular Cancer Research 21 (6), 548-563, 2023 | 4 | 2023 |
| Concomitant targeting of FLT3 and BTK with CG'806 overcomes FLT3-inhibitor resistance through inhibition of autophagy W Zhang, G Yu, H Zhang, C Ly, B Yuan, V Ruvolo, S Piya, S Bhattacharya, ... Blood 132 (Supplement 1), 2635-2635, 2018 | 4 | 2018 |
| Inhibition of Unc-51 like Autophagy Activating Kinase 1 (ULK1) Is Highly Synergistic with Chemotherapy and Bcl2 Inhibition in Acute Myeloid Leukemia (AML) S Bhattacharya, S Piya, T McQueen, M Konopleva, M Andreeff, ... Blood 130, 1248, 2017 | 4 | 2017 |
| Targeting NOTCH1-MYC-CD44 axis to eliminate leukemia initiating cells (LIC) in T-ALL S Piya, Y Yang, S Bhattacharya, H Mu, V Ruvolo, N Baran, RE Davis, ... Clinical Lymphoma, Myeloma and Leukemia 19, S196-S197, 2019 | 1 | 2019 |
| Targeting autophagy kinase ULK1 can reverse Bcl2 inhibitor (ABT-199) induced autophagy to overcome acquired resistance in acute myeloid leukemia S Bhattacharya, S Piya, Q Zhang, N Baran, T McQueen, RE Davis, ... Blood 132, 3934, 2018 | 1 | 2018 |
| BRD4 Proteolysis Targeting Chimera (PROTAC) ARV-825 Targets Both NOTCH1-MYC Regulatory Circuit and Leukemia-Microenvironment in T-ALL S Piya, H Mu, S Bhattacharya, T McQueen, RE Davis, V Ruvolo, N Baran, ... Blood 130, 716, 2017 | 1 | 2017 |
